Anti-androgen Drugs Market Report – Research, Industry Analysis Reports and Market Demands

Global Anti-androgen Drugs Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Anti-androgen Drugs Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 NSARIs
- 1.3.3 SARIs
- 1.3.4 ASIs
1.4 Market Analysis by Generation
- 1.4.1 Overview: Global Anti-androgen Drugs Consumption Value by Generation: 2021 Versus 2025 Versus 2032
- 1.4.2 1st Gen
- 1.4.3 2nd Gen
1.5 Market Analysis by Application
- 1.5.1 Overview: Global Anti-androgen Drugs Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.5.2 nmCRPC
- 1.5.3 mCRPC
- 1.5.4 mHSPC
- 1.5.5 Special Endocrine / Female
1.6 Global Anti-androgen Drugs Market Size & Forecast
- 1.6.1 Global Anti-androgen Drugs Consumption Value (2021 & 2025 & 2032)
- 1.6.2 Global Anti-androgen Drugs Sales Quantity (2021-2032)
- 1.6.3 Global Anti-androgen Drugs Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: Anti-androgen Drugs by Manufacturer

3.1 Global Anti-androgen Drugs Sales Quantity by Manufacturer (2021-2026)
3.2 Global Anti-androgen Drugs Revenue by Manufacturer (2021-2026)
3.3 Global Anti-androgen Drugs Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Anti-androgen Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Anti-androgen Drugs Manufacturer Market Share in 2025
- 3.4.3 Top 6 Anti-androgen Drugs Manufacturer Market Share in 2025
3.5 Anti-androgen Drugs Market: Overall Company Footprint Analysis
- 3.5.1 Anti-androgen Drugs Market: Region Footprint
- 3.5.2 Anti-androgen Drugs Market: Company Product Type Footprint
- 3.5.3 Anti-androgen Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Anti-androgen Drugs Market Size by Region
- 4.1.1 Global Anti-androgen Drugs Sales Quantity by Region (2021-2032)
- 4.1.2 Global Anti-androgen Drugs Consumption Value by Region (2021-2032)
- 4.1.3 Global Anti-androgen Drugs Average Price by Region (2021-2032)
4.2 North America Anti-androgen Drugs Consumption Value (2021-2032)
4.3 Europe Anti-androgen Drugs Consumption Value (2021-2032)
4.4 Asia-Pacific Anti-androgen Drugs Consumption Value (2021-2032)
4.5 South America Anti-androgen Drugs Consumption Value (2021-2032)
4.6 Middle East & Africa Anti-androgen Drugs Consumption Value (2021-2032)

5 Market Segment by Type

5.1 Global Anti-androgen Drugs Sales Quantity by Type (2021-2032)
5.2 Global Anti-androgen Drugs Consumption Value by Type (2021-2032)
5.3 Global Anti-androgen Drugs Average Price by Type (2021-2032)

6 Market Segment by Application

6.1 Global Anti-androgen Drugs Sales Quantity by Application (2021-2032)
6.2 Global Anti-androgen Drugs Consumption Value by Application (2021-2032)
6.3 Global Anti-androgen Drugs Average Price by Application (2021-2032)

7 North America

7.1 North America Anti-androgen Drugs Sales Quantity by Type (2021-2032)
7.2 North America Anti-androgen Drugs Sales Quantity by Application (2021-2032)
7.3 North America Anti-androgen Drugs Market Size by Country
- 7.3.1 North America Anti-androgen Drugs Sales Quantity by Country (2021-2032)
- 7.3.2 North America Anti-androgen Drugs Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe Anti-androgen Drugs Sales Quantity by Type (2021-2032)
8.2 Europe Anti-androgen Drugs Sales Quantity by Application (2021-2032)
8.3 Europe Anti-androgen Drugs Market Size by Country
- 8.3.1 Europe Anti-androgen Drugs Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Anti-androgen Drugs Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific Anti-androgen Drugs Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Anti-androgen Drugs Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Anti-androgen Drugs Market Size by Region
- 9.3.1 Asia-Pacific Anti-androgen Drugs Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Anti-androgen Drugs Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America Anti-androgen Drugs Sales Quantity by Type (2021-2032)
10.2 South America Anti-androgen Drugs Sales Quantity by Application (2021-2032)
10.3 South America Anti-androgen Drugs Market Size by Country
- 10.3.1 South America Anti-androgen Drugs Sales Quantity by Country (2021-2032)
- 10.3.2 South America Anti-androgen Drugs Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa Anti-androgen Drugs Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Anti-androgen Drugs Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Anti-androgen Drugs Market Size by Country
- 11.3.1 Middle East & Africa Anti-androgen Drugs Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Anti-androgen Drugs Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 Anti-androgen Drugs Market Drivers
12.2 Anti-androgen Drugs Market Restraints
12.3 Anti-androgen Drugs Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Anti-androgen Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Anti-androgen Drugs
13.3 Anti-androgen Drugs Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Anti-androgen Drugs Typical Distributors
14.3 Anti-androgen Drugs Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Anti-androgen Drugs market size was valued at US$ 7818 million in 2025 and is forecast to a readjusted size of US$ 17964 million by 2032 with a CAGR of 12.2% during review period.
Anti-androgen drugs are a class of therapeutics that inhibit androgen production, block androgen receptor (AR) signaling, or interfere with downstream androgen pathways, primarily used to treat androgen-dependent diseases, with prostate cancer as the core indication, while also covering conditions such as polycystic ovary syndrome (PCOS), hirsutism, and gender-affirming hormone therapy; the category includes non-steroidal AR inhibitors (e.g., Enzalutamide, Apalutamide, Darolutamide), steroidal anti-androgens (e.g., Cyproterone Acetate), and androgen biosynthesis inhibitors (e.g., Abiraterone Acetate), forming a comprehensive market characterized by mechanistic diversity and indication-driven demand.
This report is a detailed and comprehensive analysis for global Anti-androgen Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Anti-androgen Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Anti-androgen Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Anti-androgen Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Anti-androgen Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Anti-androgen Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Anti-androgen Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Astellas, Pfizer, Johnson & Johnson, Bayer AG, Orion, Teva Pharmaceutical, Sun Pharmaceutical, Dr. Reddy's Laboratories, Cipla, Hengrui Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Anti-androgen Drugs market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
NSARIs
SARIs
ASIs
Market segment by Generation
1st Gen
2nd Gen
Market segment by Application
nmCRPC
mCRPC
mHSPC
Special Endocrine / Female
Major players covered
Astellas
Pfizer
Johnson & Johnson
Bayer AG
Orion
Teva Pharmaceutical
Sun Pharmaceutical
Dr. Reddy's Laboratories
Cipla
Hengrui Pharmaceuticals
Lonza Group
WuXi AppTec
Asymchem Laboratories
Catalent
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-androgen Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Anti-androgen Drugs, with price, sales quantity, revenue, and global market share of Anti-androgen Drugs from 2021 to 2026.
Chapter 3, the Anti-androgen Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-androgen Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Anti-androgen Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Anti-androgen Drugs.
Chapter 14 and 15, to describe Anti-androgen Drugs sales channel, distributors, customers, research findings and conclusion.

Buy now